Fewer Disease Flares With GLP-1 Therapy In a retrospective study led by Shreya Sakthivel, Chief Resident of Internal Medicine at Anne Arundel Medical Center, investigators found that RA patients receiving disease-modifying antirheumatic drugs (DMARDs) who also took GLP-1 receptor agonists or SGLT2 inhibitors experienced fewer disease flares than those on DMARDs alone
This cost depends on your insurance coverage (copay, coinsurance, or deductibles), the pharmacy, location, and whether you use discount coupons like those offered by GoodRx, BuzzRx, WellRx, and SingleCare
P.B., a 5 7 male, aged 65, has struggled with his weight since middle school
Not just on paper, but in practice